Skip to content
FIND A HEALTH VALLEY ACTOR

Collaboration between ABCDx and Andalusian Hospitals

abcd x

ABCDx is collaborating with Andalusian hospitals to improve stroke triage inside ambulances.     Thanks to a public-private grant from the Junta de Andalucía (PIP-0009-2021), the Hospital Universitario Virgen Macarena/IBIS is leading a study to evaluate the potential use of a rapid Point-of-Care device for the direct transfer of stroke patients with a large vessel…

Read More

Six women-centred initiatives you should know about

International women days

From successful entrepreneurs to academics and industry leaders, the Swiss Health Valley is full of inspirational women working in life sciences.     As we celebrate Women International’s Day, we’re happy to highlight some of the great initiatives pushing to close the gender gap in life sciences that everybody should keep an eye on.  …

Read More

A multidisciplinary HUG team launches a new study of innovative radioligand therapy (RLT)

HUG-RLT

A new radioligand to treat glioblastoma and digestive tumors evaluated as a world first at the Geneva University Hospitals (HUG).     RLT is a nuclear medicine-based approach that destroys malignant tumors through targeted irradiation. Its specificity lies in the use of a radioactive element embedded in a chemical compound designed to bind specifically to…

Read More

Terapet receives EUR 1.68 Million Eurostars grant

Terapet announced the receipt of a non-dilutive grant totalling approximately EUR 1.68 Million from the European Commission through the Eurostars Program.     Terapet SA, is a Geneva-based CERN spin-off supported by FONGIT, developing an innovative platform technology for imaging in nuclear medicine. The received grant is supported by Innosuisse – the Swiss Innovation Agency,…

Read More

Artiria Medical, Planny and Algorized receive support from FIT

FIT-artiria-planny-algorized

The three startups have received financial support from the Foundation for technological innovation (FIT). Artiria Medical gets a Tech Growth loan to treat strokes Artiria Medical, a leader in medical device innovation for neurovascular treatments, receives a CHF 500,000 Tech Growth Loan. Their unique deflectable wire technology, which significantly improves the accuracy and speed of…

Read More

Dopamine production is not behind vulnerability to cocaine abuse

Dopamine

A UNIGE team shows that our ability to produce dopamine – the «happiness hormone» – is not correlated with increased vulnerability to drugs.     Why do some people who try drugs struggle with substance abuse while others don’t? This question has long puzzled scientists. A team from the University of Geneva (UNIGE) explored the…

Read More

Agora Care celebrates 10’000 patients and a new collaboration with Caduceo

The Campus biotech startup, recruited over 10’000 patients on its Agora Care platform.     This marks an inflection point of the acceleration of Agora Care patient recruitment from early pilot projects to extended recruitment in several large radiology and healthcare networks in Switzerland. Agora Care is developing a patient-centered platform for storage and communication…

Read More

FONGIT Innovation Fund (FIF) awards funding to Geneva-based tech projects

FONGIT FIF

A seed loan of CHF 100,000 has been granted to previous FIF Grant laureate and HUG spinoff HeroSupport. One grant of CHF 50,000 has been awarded to HUG project SmellRS.     The FIF supports innovative technological startups and scale-ups at different stages of their journey with three types of financing options: the FIF Grant…

Read More

Artiria Medical successfully secures USD 6 Million

Artiria Medical

Artiria Medical secures funding to complete its clinical studies in stroke in both Europe and the Us, following promising first in-human results and FDA clearance.     The MedTech company, developing next-generation neuro-interventional products for stroke and aneurysms, successfully closed off a Series A2 round of USD 0.6 Million. Furthermore, they secured an additional USD…

Read More

Leenaards Prize awarded to two CHUV research groups

Leenaards prize

The two Leenards scientific prizes were awarded to research groups led by CHUV researchers.     Each year, the Leenards Foundation awards scientific prizes for projects combining basic and clinical research, carried out by research groups in the Lake Geneva region. For 2024, a total of nearly CHF 1.4 million has been awarded to the…

Read More